Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB00933_nanopub.RAbFWwCEy8e7q7alehxXrk6OT9cxuW1vIXkb0gSlzqZT0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB00933 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB00933 label "DDI between Tacrine and Mesoridazine - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Mesoridazine, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents. [drugbank_resource:DB00382_DB00933]" assertion.
- drugbank_resource:DB00382_DB00933 identifier "drugbank_resource:DB00382_DB00933" assertion.
- drugbank_resource:DB00382_DB00933 title "DDI between Tacrine and Mesoridazine - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Mesoridazine, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00933 assertion.
- drugbank:DB00933 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00933 assertion.